Latest News & Articles
Browse all our latest news articles and stories
Cepton Q2 2024 Financial and Business Operations FAQ
Cepton (NASDAQ: CPTN) reported its Q2 2024 financial and business results, highlighting a merger agreement with Koito Manufacturing Co. Ltd., …
August 27, 2024
Source
SOBRsafe Q2 2024 Quarterly Update FAQ
SOBRsafe, a leader in transdermal alcohol-detection technology, has been granted an extension by NASDAQ to meet compliance requirements, while …
August 27, 2024
Source
McEwen Mining CEO's Strategic Approach to Mining Industry Perception
McEwen Mining CEO Rob McEwen highlights the mining industry's essential role in modern civilization and proposes strategies to improve its public …
August 27, 2024
Source
FAQ on CNS Pharmaceuticals Q2 2024 Results and Clinical Progress
CNS Pharmaceuticals released its Q2 2024 financial results and updated on the clinical development of its lead programs, Berubicin and TPI 287, …
August 27, 2024
Source
Scinai Immunotherapeutics Q2 2024 Financial Results and Business Update FAQ
Scinai Immunotherapeutics reported its Q2 2024 financial results, highlighting a restructuring of a $29 million bank loan to equity, progress in …
August 27, 2024
Source
Annovis Bio Q2 2024 Financial Results and Business Update FAQ
Annovis Bio (NYSE: ANVS) announced its Q2 2024 financial results and a business update, highlighting significant improvements in cognition for …
August 27, 2024
Source
HeartBeam Q2 2024 Financial Report and Operational Update FAQ
HeartBeam Inc. reports its Q2 2024 financial and operational results, highlighting progress towards FDA submission for its HeartBeam AIMIGo(TM) System …
August 27, 2024
Source
D-Wave Quantum's Expansion into AI and ML: A Comprehensive FAQ
D-Wave Quantum (NYSE: QBTS) has announced an expansion of its Leap quantum cloud service to integrate quantum computing with AI and ML, aiming to …
August 27, 2024
Source
FAQ on InMed Pharmaceuticals' INM-089 and Its Potential in Treating AMD
InMed Pharmaceuticals is making strides with INM-089, a promising treatment for age-related macular degeneration (AMD), showcasing potential benefits …
August 27, 2024
Source
FAQ: Mullen Automotive's Expansion in Higher Education with Princeton University
Mullen Automotive has sold its Mullen THREE, Class 3 EV box truck to Princeton University, supporting the university's sustainability goals and …
August 27, 2024
Source
SenesTech's Sustainable Solution to Rodent Infestation: A Comprehensive FAQ
SenesTech offers a sustainable and environmentally friendly solution to the growing rodent problem in the U.S., particularly in cities like New York, …
August 27, 2024
Source
FAQ: SuperCom's Q2 2024 Financial Results and Record Profit
SuperCom (NASDAQ: SPCB) reported its Q2 2024 financial results, showcasing a record profit with $7.5 million in revenue and $2.2 million net income, …
August 27, 2024
Source
FAQ on McEwen Mining's Acquisition of Timberline Resources
McEwen Mining has successfully acquired Timberline Resources, a move approved by Timberline shareholders, aiming to expand its operations in Nevada …
August 27, 2024
Source
FAQs on Annovis Bio's Buntanetap Alzheimer’s Study Findings
Annovis Bio presented promising Phase 2/3 study results for buntanetap, a potential breakthrough in early Alzheimer’s treatment, showing it to be …
August 27, 2024
Source
FAQ on InMed Pharmaceuticals' INM-901 Preclinical Data Announcement
InMed Pharmaceuticals announced promising preclinical data for INM-901, an oral formulation drug candidate for Alzheimer's disease, showing similar …
August 27, 2024
Source
FAQ on Scinai Immunotherapeutics' $2M Investment Commitment Agreement
Scinai Immunotherapeutics has entered into a $2 million Investment Commitment Agreement with RK Stone Miami LLC, enabling the company to issue and …
August 27, 2024
Source
D-Wave Quantum's Q2 2024 Financial Results and Business Updates FAQ
D-Wave Quantum (NYSE: QBTS) reported significant growth in Q2 2024, including a 28% increase in revenue and a 444% increase in cash, alongside …
August 27, 2024
Source
FAQ on Mullen Automotive's Subsidiary Bollinger Motors Starting Production of the Bollinger B4 Chassis Cab
Mullen Automotive's subsidiary, Bollinger Motors, is set to begin production of the all-new Class 4 commercial EV truck, the Bollinger B4 Chassis Cab, …
August 27, 2024
Source
FAQ on Scinai Immunotherapeutics' Loan Restructuring Agreement with EIB
Scinai Immunotherapeutics has finalized a loan restructuring agreement with the European Investment Bank, converting approximately EUR 26.6 million of …
August 27, 2024
Source
